腎臓内科・泌尿器科市場レポート：2030年までの動向、予測、競合分析

腎臓内科・泌尿器科の動向と予測

世界の腎臓内科・泌尿器科市場の将来は、病院、診療所、外来手術センター市場での機会により有望視されています。世界の腎臓内科・泌尿器科市場は、2024年から2030年までのCAGRが6.6%で、2030年までに推定97億米ドルに達すると予想されます。この市場の主な促進要因は、慢性疾患の有病率の上昇、透析患者数の増加、低侵襲（MI）機器への嗜好の高まりです。

• Lucintel社の予測では、製品カテゴリーでは、経皮的腎瘻造設カテーテルが、腎移植による問題の治療、腎臓または腎周囲液貯留の減圧、非拡張閉塞療法に大きく使用されるため、予測期間中に最も高い成長が見込まれています。
• 最終用途のカテゴリーでは、腎疾患患者の入院の増加、高度な治療装置の容易な入手可能性、医療施設で透析を受ける患者の増加により、病院が最大のセグメントであり続けると思われます。
• 地域別では、腎臓病患者の増加、熟練した医師の存在、確立されたヘルスケア施設の存在により、北米が予測期間中に最も高い成長を示すと予想されます。

腎臓内科・泌尿器科市場の戦略的成長機会

さまざまな応用例などにより、この分野には戦略的な成長機会が生まれています。

• 遠隔医療の拡大：遠隔医療サービスの拡大には、患者管理を強化するだけでなく、医療アクセスを向上させるという重要な手段があります。十分なサービスを受けていない人々へのサービスギャップを埋めるために、強固な遠隔医療プラットフォームを開発する必要があります。
• ロボット手術システム：ロボット手術システムへの投資家になることは、最先端の手術ソリューションを提供することから、成長のチャンスをもたらします。臨床の場では、泌尿器科手術の精度と結果を向上させる。
• 人工腎臓技術の進歩は、透析市場の成長機会につながります。つまり、慢性腎臓病管理をより効果的かつ便利にすることを目的とした技術革新が、このアンメットニーズに対応できることを意味します。
• 個別化治療ソリューション：腎臓学や泌尿器学の分野では、こうした患者データを活用した個別化医療のアプローチが成長をもたらす可能性があります。その結果、こうした開発によって治療成績や患者の満足度が向上することが期待されます。
• 診断ツールの革新：腎臓・泌尿器疾患の早期発見とモニタリングは、利用可能な診断ツールの種類を増やすことで改善される可能性があります。その結果、画像診断やバイオマーカー検査の進歩が診断精度を高めることになります。

このような機会は、技術革新を促進し、患者ケアを改善することで、腎臓内科・泌尿器科市場を形成しています。

腎臓内科・泌尿器科市場の促進要因・課題

腎臓内科・泌尿器科市場は、様々な促進要因の影響を受けており、その成長だけでなく市場開拓にも影響を与える主要な課題でもあります。

腎臓内科・泌尿器科市場の促進要因には以下のようなものがあります：

• 技術の進歩：革新的な診断ツール、手術技術、デジタルヘルスソリューションの使用は、この市場セグメントの増加を促進します。これらの改善により、特に泌尿器科医に関しては、腎臓内科治療全体の効率と有効性が向上します。
• 腎臓および泌尿器疾患の発生率の上昇：腎臓および泌尿器疾患の有病率の増加は、より洗練された治療オプションの必要性につながっています。この動向は、新しい技術や治療法の開発・普及を後押ししています。
• 個別化医療への注目の高まり：個別化医療へのシフトは、個々の患者のプロファイルに合わせて医療レジメンを調整することで、治療成績を向上させています。泌尿器科だけでなく、腎臓内科でもこのような方法が認識されつつあります。
• 遠隔医療サービスの拡大：遠隔医療サービスの増加は、治療へのアクセスを向上させ、患者管理を改善しています。腎臓内科や泌尿器科の治療では、遠隔診察やモニタリングが取り入れられ始めています。
• 研究開発投資の増加：この資金は、研究開発への投資を通じて、腎臓学および泌尿器学の技術の進歩を促進します。特に、新しい治療法や診断ツールの開発を支援しています。

腎臓内科・泌尿器科市場の課題は以下のとおりである：

• 先端技術のコスト高：先端技術機器の高価格は、その導入の障害となる可能性があります。ヘルスケアプロバイダーと患者は、コストとアクセシビリティのバランスを取るという課題に直面しています。
• 規制とコンプライアンスの問題：迷路のような規制要件を交渉しながら、確実に基準を満たすことは、問題になりうる。新規製品の市場参入や認可などの問題に影響します。
• データ・プライバシーへの懸念：患者データのセキュリティとプライバシーを確実に守ることは大きな課題です。信頼を維持するためには、データ保護のルールを遵守し、患者のニーズに応えることが不可欠です。

腎臓内科・泌尿器科市場は、イノベーション、購買決定、規制要件に影響を与えるこれらの原動力と課題によって形成されています。

目次

第1章 エグゼクティブサマリー

第2章 世界の腎臓内科・泌尿器科市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
• 世界の腎臓内科・泌尿器科市場の動向（2018年～2023年）と予測（2024年～2030年）
• 世界の腎臓内科・泌尿器科市場：製品別
  • 尿管カテーテル
  • PCNカテーテル
  • 尿管ステント
  • 石のバスケット
  • 泌尿器科ガイドワイヤー
  • 腎拡張薬
  • その他
• 世界の腎臓内科・泌尿器科市場：用途別
  • 尿路結石症
  • 泌尿器がんと前立腺肥大症
  • 膀胱障害
  • 腎臓疾患
  • その他
• 世界の腎臓内科・泌尿器科市場：最終用途産業別
  • 病院
  • クリニック
  • 外来手術センター
  • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別の世界の腎臓内科・泌尿器科市場
• 北米の腎臓内科・泌尿器科市場
• 欧州の腎臓内科・泌尿器科市場
• アジア太平洋の腎臓内科・泌尿器科市場
• その他地域の腎臓内科・泌尿器科市場

第5章 競合分析

• 製品ポートフォリオ分析
• 業務統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 製品別世界の腎臓内科・泌尿器科市場の成長機会
  • 世界の腎臓内科・泌尿器科市場におけるアプリケーション別の成長機会
  • 最終用途産業別世界の腎臓内科・泌尿器科市場の成長機会
  • 世界の腎臓内科・泌尿器科市場地域の成長機会
• 世界の腎臓内科・泌尿器科市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の腎臓内科・泌尿器科市場の能力拡大
  • 世界の腎臓内科・泌尿器科市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Medtronic
• Coloplast
• Boston Scientific
• ConvaTec
• B. Braun
• Hollister
• Teleflex
• Baxter
• Fresenius Medical Care
• Asahi Kasei

Nephrology and Urology Trends and Forecast

The future of the global nephrology and urology market looks promising with opportunities in the hospital, clinic, and ambulatory surgical center markets. The global nephrology and urology market is expected to reach an estimated $9.7 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are the rising prevalence of chronic diseases, the increasing number of dialysis patients, and the growing preference for minimally invasive (MI) devices.

• Lucintel forecast that, within the product category, the percutaneous nephrostomy catheter is expected to witness the highest growth over the forecast period due to its significant use in treating problems from kidney transplants, decompressing nephric or perinephric fluid collection, and non-dilated obstructive therapies.
• Within the end-use category, hospitals will remain the largest segment due to the increasing admission of renal disease patients, easy availability of advanced treatment devices, and the growing number of patients obtaining dialysis in medical facilities.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the growing number of kidney-affected patients, the presence of skilled physicians, and the availability of well-established healthcare facilities in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Nephrology and Urology Market

Emerging trends in the nephrology and urology market have a bearing on future care given advances in technology as well as changing patient needs.

• Integration of Artificial Intelligence: AI is progressively finding its way into diagnostic systems as well as treatment options available for nephrologists and urologists. AI algorithms are essential in improving diagnostics' accuracy, personalizing treatment plans, as well as enhancing predictive analytics thereby leading to improved patient outcomes.
• Advancements in Minimally Invasive Surgery: The use of minimally invasive techniques such as laparoscopic surgery and robot-assisted surgery has been gaining popularity among surgeons. These approaches minimize complications, hasten recovery, and offer more accurate treatments thus benefiting patients.
• Expansion of Telehealth Services: Telehealth technology is now being used more often by nephrologists and urologists allowing them to provide consultations remotely or monitor their patients over time. This trend makes it easier for all people regardless of their place of living to access healthcare services also simplifying the management of chronic conditions.
• Focus on Personalized Medicine: Personalized medicine is catching on with treatments that fit individual genetic formulae and target specific health conditions. This model intends to maximize therapeutic effectiveness while minimizing side effects by customizing care using patient-specific data.
• Development of Advanced Diagnostic Tools: Improved imaging techniques and biomarker-based tests are being witnessed in the field of diagnostics. These developments enable early detection and more accurate diagnosis of urology and kidney-related ailments.

These trends enhance diagnostic precision, treatment efficiency, and patient reachability; consequently reshaping the nephrology & urology market.

Recent Developments in the Nephrology and Urology Market

Advancements in technology and new treatment methods characterize the recent important developments in the nephrology and urology market.

• Artificial Kidney Technologies: The artificial kidney technologies under development aim at improving dialysis efficiency as well as patients' comfort during therapy procedures. They mainly focus on designing wearable or implantable devices that mimic kidney functions better than ever before.
• Robotic-Assisted Surgeries: Robotic-assisted surgery systems have been introduced into urological practice which has led to a revolution in urological operations. These assistive machines provide a higher level of precision and control, thus reducing complications while also speeding up recovery time.
• Telehealth Integration: Telehealth's growth has improved the management of nephrology and urology at a distance. It is leading to greater patient involvement and increased availability through virtual consultations and remote monitoring tools.
• Advanced Imaging Techniques: Modern imaging techniques, such as high-resolution MRI, and 3D ultrasound are improving diagnosis accuracy and treatment planning for renal and urological diseases.
• Personalized Medicine Approaches: Personalized medicine has been taken up which facilitates individualized therapy based on patient profiles, leading to better outcomes in treatment while minimizing side effects.

These developments are driving innovation and improving the quality of care in nephrology and urology.

Strategic Growth Opportunities for Nephrology and Urology Market

Various applications among others have led to strategic growth opportunities emerging in this field.

• Telemedicine Expansion: A significant avenue for expansion of telemedicine services is offered by increasing care access as well as enhancing patient management. To bridge service gaps reaching underserved populations; robust telehealth platforms should be developed.
• Robotic Surgery Systems: Becoming an investor in robotic surgery systems brings about chances for growth as it provides state-of-the-art surgical solutions. In clinical settings, these systems promote precision and outcomes during urological surgeries.
• Advances in artificial kidney technologies can lead to growth opportunities in the dialysis market. This, therefore, means that innovations aimed at making chronic kidney disease management more effective and convenient would be able to address this unmet need.
• Personalized Treatment Solutions: Growth can result from personalized medicine approaches that utilize such patient data in the field of nephrology and urology. As a result, these developments are expected to improve therapeutic outcomes and satisfaction levels among patients.
• Innovations in Diagnostic Tools: Early detection and monitoring of kidney and urological diseases may be improved through expanding the variety of diagnostic tools available. Consequently, advances in imaging as well as biomarker testing are poised to increase diagnostic accuracy.

These opportunities are shaping the Nephrology and Urology market by driving innovation and improving patient care.

Nephrology and Urology Market Driver and Challenges

The nephrology and urology market is influenced by various drivers, which are also major challenges that affect its growth as well as development.

The factors responsible for driving the nephrology and urology market include:

• Technological Advancements: The use of innovative diagnostic tools, surgical techniques, and digital health solutions drives the increase of this market segment. These improvements lift efficiency as well as effectiveness throughout nephrology care especially when it comes to urologists.
• Rising Incidence of Kidney and Urological Disorders: The increasing prevalence of renal and urogenital conditions is leading to the need for more sophisticated treatment options. This trend pushes forward the development and uptake of new technologies and therapies.
• Growing Focus on Personalized Medicine: A shift toward personalized healthcare has increased successful treatment outcomes by adjusting medical regimens to suit individual patient profiles. Such a method is being recognized in nephrology as well as urology.
• Expansion of Telehealth Services: The increasing growth in telehealth services is enhancing access to care and improving patient management. Nephrology and urology care are beginning to incorporate remote consultation and monitoring.
• Increased Research and Development Investment: This funding promotes the advancement of nephrology as well as urology technologies through investment in research and development. It supports the creation of fresh therapeutic methods and diagnostic tools among other things.

Challenges in the nephrology and urology market are:

• High Costs of Advanced Technologies: High prices for advanced technological devices can act as an obstacle to their adoption. Healthcare providers together with patients face a challenge in striking a balance between cost and accessibility.
• Regulatory and Compliance Issues: Negotiating labyrinthine regulatory requirements while ensuring standards are met can be problematical. They affect issues like entry into the market or clearance for novel products.
• Data Privacy Fears: It is a big task to ensure that patient data security and privacy are observed. To maintain trust, compliance with the rules of data protection and responding to patients' needs are essential.

The nephrology and urology market is being shaped by these driving forces and challenges by affecting innovation, purchase decisions as well as regulatory requirements.

List of Nephrology and Urology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nephrology and urology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nephrology and urology companies profiled in this report include-

• Medtronic
• Coloplast
• Boston Scientific
• ConvaTec
• B. Braun
• Hollister
• Teleflex
• Baxter
• Fresenius Medical Care
• Asahi Kasei

Nephrology and Urology by Segment

The study includes a forecast for the global nephrology and urology by product, application, end use industry, technology, and region

Nephrology and Urology Market by Product [Analysis by Value from 2018 to 2030]:

• Ureteral Catheters
• PCN Catheters
• Urinary Stents
• Stone Basket
• Urology Guidewires
• Renal Dilators

Nephrology and Urology Market by Application [Analysis by Value from 2018 to 2030]:

• Urolithiasis
• Urological Cancer & BPH
• Bladder Disorders
• Kidney Diseases
• Others

Nephrology and Urology Market by End Use Industry [Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Nephrology and Urology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Nephrology and Urology Market

The latest trends in the nephrology and urology market show innovative treatment technologies and a growing global attention to patient-centered care.

• United States: The United States has witnessed significant milestones towards managing kidney diseases including the use of artificial kidneys and improved dialysis techniques. There is also an increasing trend for personalized medical care as well as telehealth solutions meant to enhance patients' outcomes in nephrology and urology.
• China: Technological advancements in China have led to the rapid development of advanced diagnostic tools alongside minimal invasive surgical approaches. These include imaging innovations as well as robotic-assisted surgeries that are increasingly used to improve the efficiency of care processes and reduce recovery periods for patients with nephrological or urological conditions.
• Germany: Germany is leading in digital health integration into nephrology and urology care. Most recently, there have been developments such as advanced telemedicine platforms and electronic health records for adequate management of chronic kidney diseases plus complex urological procedures support.
• India: In India, however, there has been a focus on expanding access to nephrology/urology through affordable options & creation of specialized centers. Consequently, new technologies are being developed while existing ones are being refined so that they can be able to cope with the increasing number of renal disorders & urogenital abnormalities.
• Japan: Japan is at the forefront of developing high-precision diagnostic tools and treatment technologies for nephrology and urology. Recent milestones include state-of-the-art imaging methods and robots with surgical precision that facilitate better results for patients.

Features of the Global Nephrology and Urology Market

Market Size Estimates: Nephrology and urology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nephrology and urology market size by product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Nephrology and urology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the nephrology and urology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nephrology and urology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the nephrology and urology market by product (ureteral catheters, PCN catheters, urinary stents, stone basket, urology guidewires, renal dilators, and others), application (urolithiasis, urological cancer & BPH, bladder disorders, kidney diseases, and others), end use industry (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nephrology and Urology Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Nephrology and Urology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Nephrology and Urology Market by Product
  • 3.3.1: Ureteral Catheters
  • 3.3.2: PCN Catheters
  • 3.3.3: Urinary Stents
  • 3.3.4: Stone Basket
  • 3.3.5: Urology Guidewires
  • 3.3.6: Renal Dilators
  • 3.3.7: Others
• 3.4: Global Nephrology and Urology Market by Application
  • 3.4.1: Urolithiasis
  • 3.4.2: Urological Cancer & BPH
  • 3.4.3: Bladder Disorders
  • 3.4.4: Kidney Diseases
  • 3.4.5: Others
• 3.5: Global Nephrology and Urology Market by End Use Industry
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Ambulatory Surgical Centers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Nephrology and Urology Market by Region
• 4.2: North American Nephrology and Urology Market
  • 4.2.1: North American Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.2.2: North American Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.3: European Nephrology and Urology Market
  • 4.3.1: European Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.3.2: European Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.4: APAC Nephrology and Urology Market
  • 4.4.1: APAC Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.4.2: APAC Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.5: ROW Nephrology and Urology Market
  • 4.5.1: ROW Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.5.2: ROW Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Nephrology and Urology Market by Product
  • 6.1.2: Growth Opportunities for the Global Nephrology and Urology Market by Application
  • 6.1.3: Growth Opportunities for the Global Nephrology and Urology Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Nephrology and Urology Market Region
• 6.2: Emerging Trends in the Global Nephrology and Urology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Nephrology and Urology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nephrology and Urology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Medtronic
• 7.2: Coloplast
• 7.3: Boston Scientific
• 7.4: ConvaTec
• 7.5: B. Braun
• 7.6: Hollister
• 7.7: Teleflex
• 7.8: Baxter
• 7.9: Fresenius Medical Care
• 7.10: Asahi Kasei